| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 07/15/2004 | WO2004058306A1 Tumor supression through bicistronic co-expression of p53 and p14arf |
| 07/15/2004 | WO2004058192A2 Reversible masking of liposomal complexes for targeted delivery |
| 07/15/2004 | WO2004058191A2 Multivalent lymphotoxin beta receptor agonists and therapeutic uses thereof |
| 07/15/2004 | WO2004058188A2 Vaccine compositions and methods |
| 07/15/2004 | WO2004058179A2 Immunostimulatory sequence oligonucleotides and methods of using the same |
| 07/15/2004 | WO2004058175A2 Novel use of liver x receptor agonists |
| 07/15/2004 | WO2004058157A2 Yeast-based vaccines as immunotherapy |
| 07/15/2004 | WO2004058147A2 Human chondroitinase glycoprotein (chasegp), process for preparing the same, and pharmaceutical compositions comprising thereof |
| 07/15/2004 | WO2004058052A2 Genetic polymorphisms associated with myocardial infarction, methods of detection and uses thereof |
| 07/15/2004 | WO2004058042A2 Methods for evaluating genetic susceptibility and therapy for chronic inflammatory diseases |
| 07/15/2004 | WO2004057946A2 Method for altering the content of reserve substances in plants |
| 07/15/2004 | WO2004057941A2 RECESSIVE PLANT VIRAL RESISTANCE RESULTS FROM MUTATIONS IN TRANSLATION INITIATION FACTOR eIF4E |
| 07/15/2004 | WO2004048606A3 Porcine polymorphisms and methods for detecting them |
| 07/15/2004 | WO2004047853A3 Methods for the treatment of chronic pain and compositions therefor |
| 07/15/2004 | WO2004046346A3 Self-containing lactobacillus strain |
| 07/15/2004 | WO2004046325A3 Modulation of serine/threonine kinase 16 expression |
| 07/15/2004 | WO2004046320A3 METHODS AND COMPOSITIONS FOR REDUCING TARGET GENE EXPRESSION USING COCKTAILS OF siRNAS OR CONSTRUCTS EXPRESSING siRNAS |
| 07/15/2004 | WO2004046190A3 Antibodies lacking vacuolar targeting signal peptide and capable of binding j-chain |
| 07/15/2004 | WO2004044221A3 High throughput automatic nucleic acid isolation and quantitation methods |
| 07/15/2004 | WO2004042363A3 In vivo imaging of e2f-regulated bioluminescent proteins |
| 07/15/2004 | WO2004042027A3 Allele-specific rna interference |
| 07/15/2004 | WO2004041865A3 Stabilized single domain antibodies |
| 07/15/2004 | WO2004041863A3 Single domain antibodies directed against interferon- gamma and uses therefor |
| 07/15/2004 | WO2004037848A9 Process for determining target function and identifying drug leads |
| 07/15/2004 | WO2004035626A8 Alpha macroglobulin protein family members |
| 07/15/2004 | WO2004034956A3 8-plasmid method with mutated ha gene for producing an influenza vaccine |
| 07/15/2004 | WO2004032599A3 Novel immunogenic proteins of leptospira |
| 07/15/2004 | WO2004031375A3 Regulation of human 3’, 5’ cyclic nucleotide phosphodiesterase pde1c |
| 07/15/2004 | WO2004031357A3 Targeted tumor therapy by use of recombinant adenovirus vectors that selectively replicate in hypoxic regions of tumors |
| 07/15/2004 | WO2004031224A3 Hbv mutations associated with reduced susceptibility to adefovir |
| 07/15/2004 | WO2004030630A3 Focal calcium channel modulation |
| 07/15/2004 | WO2004029280A3 Anti-hla assay and methods |
| 07/15/2004 | WO2004028442A3 Use of excipients to increase dna uptake by swine muscle cells |
| 07/15/2004 | WO2004028239A3 Mammal model for autoimmune diseases with dysfunction of socs-1 gene |
| 07/15/2004 | WO2004026260A3 Prophylactic and therapeutic hiv aptamers |
| 07/15/2004 | WO2004024879A3 RORs AS MODIFIERS OF THE p21 PATHWAY AND METHODS OF USE |
| 07/15/2004 | WO2004024744A3 Production of glycosylated macrolides in e. coli |
| 07/15/2004 | WO2004023146A3 Methods for assaying protein-protein interactions |
| 07/15/2004 | WO2004022593A3 Rational evolution of cytokines for higher stability, the cytokines and encoding nucleic acid molecules |
| 07/15/2004 | WO2004022006A3 Methods of diagnosing cervical cancer |
| 07/15/2004 | WO2004019878A3 Adzymes and uses thereof |
| 07/15/2004 | WO2004015089A3 Polyionic organic acid formulations |
| 07/15/2004 | WO2004013333A3 Inversion of the negative-selective effect of negative marker proteins using selection methods |
| 07/15/2004 | WO2004007664A3 Nucleic acid vectors |
| 07/15/2004 | WO2004005478A2 Ketone ligands for modulating the expression of exogenous genes via an ecdysone receptor complex |
| 07/15/2004 | WO2004005322A3 Humanized renilla reniformis green fluorescent protein as a scaffold |
| 07/15/2004 | WO2004002535A8 Use of an npy y2 receptor antagonist for treating disorders related to angiogenesis |
| 07/15/2004 | WO2003106681A3 Antisense oligonucleotides against pim1 |
| 07/15/2004 | WO2003106647A3 Antisense modulation of junctional adhesion molecule 3 expression |
| 07/15/2004 | WO2003104251A3 Composition and methods for obtaining nucleic acids from sputum |
| 07/15/2004 | WO2003102239B1 Met/fret based method of target nucleic acid detection whereby the donor/acceptor moieties are on complementary strands |
| 07/15/2004 | WO2003100033A3 ANTI-αvβ6 ANTIBODIES |
| 07/15/2004 | WO2003100022A3 Methods and dna constructs for high yield production of polypeptides |
| 07/15/2004 | WO2003099209A3 Compositions and methods for screening and identifying anti-hcv agents |
| 07/15/2004 | WO2003097808A3 Automated system for isolating, amplyifying and detecting a target nucleic acid sequence |
| 07/15/2004 | WO2003093431A3 Ablated slam-dependent entry |
| 07/15/2004 | WO2003093422A3 Novel tissue factor targeted antibodies as anticoagulants |
| 07/15/2004 | WO2003092715A3 Proteins involved in the regulation of energy homeostasis |
| 07/15/2004 | WO2003089612A3 IMPROVED rAAV VECTORS |
| 07/15/2004 | WO2003087391A3 Hydrophobic zone device |
| 07/15/2004 | WO2003083056A3 Secretion of proteins with multiple disulfide bonds in bacteria and uses thereof |
| 07/15/2004 | WO2003070965A9 The eaat2 promoter and uses thereof |
| 07/15/2004 | WO2003070883A3 Methods and compositions for treating aids and hiv-related disorders using 1414, 1481, 1553, 34021, 1720, 1683, 1552, 1682, 1675, 12825, 9952, 5816, 10002, 1611, 1371, 14324, 126, 270, 312, 167, 326, 18926, 6747, 1793, 1784, or 2045 molecules. |
| 07/15/2004 | WO2003065793A3 Generation of multiple embryo maize |
| 07/15/2004 | WO2003063893B1 Fgfr agonists |
| 07/15/2004 | WO2003057142A3 Antisense modulation of macrophage inflammatory protein 3-alpha expression |
| 07/15/2004 | WO2003051912A9 Purified hepatitis c virus envelope proteins for diagnostic and therapeutic use |
| 07/15/2004 | WO2003047506A3 Peptide agonists of prostate-specific antigen, and uses therefor |
| 07/15/2004 | WO2003045312A3 Biosynthetic gene cluster for the maytansinoid antitumor agent ansamitocin |
| 07/15/2004 | WO2003044162A3 Genes encoding g-protein coupled receptors and methods of use therefor |
| 07/15/2004 | WO2003035839A3 Target specific screening andits use for identifying target binders |
| 07/15/2004 | WO2003018751A3 Apparatus and method for electroporation of biological samples |
| 07/15/2004 | WO2002101074A3 Nucleic acid constructs useful for glucose regulated production of human insulin in somatic cell lines |
| 07/15/2004 | WO2002081636A3 Protein modification and maintenance molecules |
| 07/15/2004 | WO2002072811A3 Human prenylcysteine lyase-like protein |
| 07/15/2004 | WO2002066613A3 Novel ecdysone receptor/invertebrate retinoid x receptor-based inducible gene expression system |
| 07/15/2004 | WO2002018619A3 Nucleic acid constructs including a novel t-cell active promoter, and pharmaceutical compositions and methods utilizing same for regulating t-cell mediated immune response |
| 07/15/2004 | US20040139506 Auxin-repressed, dormancy-associated promoter and uses thereof |
| 07/15/2004 | US20040139505 Method for obtaining plants exhibiting enhanced resistance to water stress |
| 07/15/2004 | US20040139504 Suppression of specific classes of soybean seed protein genes |
| 07/15/2004 | US20040139503 Suppression of specific classes of soybean seed protein genes |
| 07/15/2004 | US20040139502 Suppression of specific classes of soybean seed protein genes |
| 07/15/2004 | US20040139501 Expression vector coding linalool synthase (LIS)promoter for use as tool in controlling tissue directed heterologous gene expression in plants; tissue engineering |
| 07/15/2004 | US20040139500 Plastid division and related genes and proteins, and methods of use |
| 07/15/2004 | US20040139499 encoded by a nucleic acid isolated from a Euphorbia lagascae developing seed cDNA library; chimeras; genetic engineering |
| 07/15/2004 | US20040139498 Membrane achoring fusion protein comprising activity associated with decreasing concentration of very long chain fatty acids in seed for enhancing edibility of animal feeds; tissue engineering |
| 07/15/2004 | US20040139497 Comprises expression vector coding insecticidal polypeptide for use in generation and propagation of insect resistant plants; boiological pest control |
| 07/15/2004 | US20040139496 may be derived from a single species or may be hybrid in nature; for biosynthesis; open reading frames; genetic engineering |
| 07/15/2004 | US20040139495 Control of bacterial infection by quenching quorum-sensing of plant pathogenic bacteria |
| 07/15/2004 | US20040139494 Infection resistant plants and methods for their generation |
| 07/15/2004 | US20040139493 Transgenic seeds for propagating disease, herbicide and insect resistant corn; tissue engineering |
| 07/15/2004 | US20040139492 Genes encoding sulfate assimilation proteins |
| 07/15/2004 | US20040139489 Method for generating cloned animals using chromosome shuffling |
| 07/15/2004 | US20040139488 Compositions and methods for enhancing disease resistance in fish |
| 07/15/2004 | US20040139487 Transgenic animal and uses thereof |
| 07/15/2004 | US20040139484 Ras p27 animal models and uses thereof |
| 07/15/2004 | US20040138443 Comprises nucleotide sequences coding interleukin receptor ligand for enhancing stimulation and regulation of host response to injury and infection |
| 07/15/2004 | US20040138442 Novel human transporter proteins and polynucleotides encoding the same |
| 07/15/2004 | US20040138430 Novel polypeptide compose substance for promoting blood and blood vessel cell growth |
| 07/15/2004 | US20040138426 Protein recovery |